• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rasal2通过调节Rab27a抑制三阴性乳腺癌进展过程中的自噬性外泌体分泌。

Rasal2 inhibits autophagic-exosomes secretion via regulating Rab27a in triple-negative breast cancer progression.

作者信息

Wang Xuan, Qi Guocui, Yang Kunning, Ma Linlin, Kang Yuansai, Tang Xiaojing, Han YanTao

机构信息

Department of Pharmacology, School of Basic Medicine, Qingdao University, 308 Ningxia Road, Qingdao, 266071, China.

Department of Respiratory Medicine, Weifang Second People's Hospital, Weifang, China.

出版信息

J Transl Med. 2025 May 14;23(1):544. doi: 10.1186/s12967-025-06530-2.

DOI:10.1186/s12967-025-06530-2
PMID:40369567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12079882/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) is a subtype with the worst prognosis and there is still a lack of effective treatment. Exosomes (Exos) secreted by cancer cells to tumor microenvironment play an important role in cancer progression. We have demonstrated that the function of Rasal2 in the modulation of breast cancer progression is exos-mediated, but the relationship between Rasal2 and exosome secretion remains elusive.

METHODS

Rasal2 knock-out (KO) MDA-MB-231 cells were conducted by crispr-cas9 technique and Rab27a knock-down (KD) in Rasal2 KO MDA-MB-231 cells (KO + KD) were further established by siRNA-mate plus transfection Reagent. Control (CT)/KO MDA-MB-231 cells stably overexpressing GFP-LC3 were generated by using GFP-LC3 plamisd. Transmission electron microscope (TEM), nanoparticle tracking analysis (NTA) and western blot analysis (WB) were used to identify exos derived from TNBC. Confocal microscopy was used to observe the autophagic flux and the colocalization of autophagosomes and multivesicular bodies (MVBs). Co-immunoprecipitation analysis was performed to determine the interaction between Rasal2 and Rab27a. Immunohistochemical analysis were used to detect the expression levels of autophagy-related proteins in tumor tissues of xenograft mice inoculated with CT/KO/KO + KD MDA-MB-231 cells.

RESULTS

In this paper, we found that Rasal2 KO disrupts autophagic flux and induces secretory autophagy to promote autophagic-exos secretion in TNBC. Moreover, Rasal2 inhibits the activity of Rab27a which regulates vesicles transport and fusion, and Rab27a mediates Rasal2 KO-induced autophagic-exos secretion. Additionally, Rab27a KD inhibits Rasal2 KO-induced secretory autophagy, thereby promoting TNBC progression both in vivo and in vitro.

CONCLUSIONS

Collectively, these findings delineated the role of Rab27a in TNBC progression modulated by Rasal2 through autophagy-exos pathway and suggested that it is of great significance for the early diagnosis, targeted therapy and prognosis judgement of TNBC from the perspective of tumor microenvironment.

摘要

背景

三阴性乳腺癌(TNBC)是预后最差的一种亚型,目前仍缺乏有效的治疗方法。癌细胞分泌到肿瘤微环境中的外泌体(Exos)在癌症进展中起重要作用。我们已经证明Rasal2在调节乳腺癌进展中的功能是由外泌体介导的,但Rasal2与外泌体分泌之间的关系仍不清楚。

方法

采用crispr-cas9技术构建Rasal2基因敲除(KO)的MDA-MB-231细胞,并通过siRNA-mate加转染试剂在Rasal2基因敲除的MDA-MB-231细胞(KO + KD)中进一步敲低Rab27a。使用GFP-LC3质粒构建稳定过表达GFP-LC3的对照(CT)/KO MDA-MB-231细胞。通过透射电子显微镜(TEM)、纳米颗粒跟踪分析(NTA)和蛋白质免疫印迹分析(WB)鉴定源自TNBC的外泌体。利用共聚焦显微镜观察自噬流以及自噬体与多囊泡体(MVBs)的共定位。进行免疫共沉淀分析以确定Rasal2与Rab27a之间的相互作用。采用免疫组织化学分析检测接种CT/KO/KO + KD MDA-MB-231细胞的异种移植小鼠肿瘤组织中自噬相关蛋白的表达水平。

结果

在本文中,我们发现Rasal2基因敲除会破坏自噬流并诱导分泌性自噬,从而促进TNBC中自噬外泌体的分泌。此外,Rasal2抑制调节囊泡运输和融合的Rab27a的活性,并且Rab27a介导Rasal2基因敲除诱导的自噬外泌体分泌。此外,Rab27a基因敲低抑制Rasal2基因敲除诱导的分泌性自噬,从而在体内和体外促进TNBC进展。

结论

总的来说,这些发现阐明了Rab27a在Rasal2通过自噬外泌体途径调节TNBC进展中的作用,并表明从肿瘤微环境的角度来看,这对TNBC的早期诊断、靶向治疗和预后判断具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/78fc8d8cba78/12967_2025_6530_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/478e560da98b/12967_2025_6530_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/edce62ed7106/12967_2025_6530_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/0cb3417a711b/12967_2025_6530_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/e4c387a4b48c/12967_2025_6530_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/8ec2aeff3c4d/12967_2025_6530_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/5ea4d5004bab/12967_2025_6530_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/78fc8d8cba78/12967_2025_6530_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/478e560da98b/12967_2025_6530_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/edce62ed7106/12967_2025_6530_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/0cb3417a711b/12967_2025_6530_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/e4c387a4b48c/12967_2025_6530_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/8ec2aeff3c4d/12967_2025_6530_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/5ea4d5004bab/12967_2025_6530_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4715/12079882/78fc8d8cba78/12967_2025_6530_Fig7_HTML.jpg

相似文献

1
Rasal2 inhibits autophagic-exosomes secretion via regulating Rab27a in triple-negative breast cancer progression.Rasal2通过调节Rab27a抑制三阴性乳腺癌进展过程中的自噬性外泌体分泌。
J Transl Med. 2025 May 14;23(1):544. doi: 10.1186/s12967-025-06530-2.
2
Rasal2 suppresses breast cancer cell proliferation modulated by secretory autophagy.Rasal2 抑制受分泌自噬调控的乳腺癌细胞增殖。
Mol Cell Biochem. 2019 Dec;462(1-2):115-122. doi: 10.1007/s11010-019-03615-7. Epub 2019 Aug 31.
3
Role of Acorus calamus extract in reducing exosome secretion by targeting Rab27a and nSMase2: a therapeutic approach for breast cancer.菖蒲提取物通过靶向Rab27a和nSMase2减少外泌体分泌的作用:一种乳腺癌的治疗方法
Mol Biol Rep. 2025 Jan 15;52(1):124. doi: 10.1007/s11033-024-10203-6.
4
Hypoxic BMSC-derived exosomal miR-210-3p promotes progression of triple-negative breast cancer cells via NFIX-Wnt/β-catenin signaling axis.缺氧的骨髓间充质干细胞衍生的外泌体miR-210-3p通过NFIX-Wnt/β-连环蛋白信号轴促进三阴性乳腺癌细胞的进展。
J Transl Med. 2025 Jan 9;23(1):39. doi: 10.1186/s12967-024-05947-5.
5
[Silencing RAB27a inhibits proliferation, invasion and adhesion of triple-negative breast cancer cells].沉默RAB27a抑制三阴性乳腺癌细胞的增殖、侵袭和黏附
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Apr 20;43(4):560-567. doi: 10.12122/j.issn.1673-4254.2023.04.08.
6
Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.斑蝥素通过在体外和体内抑制自噬和诱导凋亡来抑制三阴性乳腺癌细胞的生长。
Cell Physiol Biochem. 2017;43(5):1829-1840. doi: 10.1159/000484069. Epub 2017 Oct 19.
7
Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.胸腺醌通过抑制自噬、Beclin-1 和 LC3 抑制 MDA-MB-231 三阴性乳腺癌细胞的增殖和迁移。
Anticancer Agents Med Chem. 2021;21(3):355-364. doi: 10.2174/1871520620666200807221047.
8
Noncancerous Exosomes Establish a Growth Promoting Paracrine Effect on Triple Negative Breast Cancer Cells.非癌性外泌体对三阴性乳腺癌细胞建立促生长旁分泌效应。
Anticancer Res. 2025 Feb;45(2):419-431. doi: 10.21873/anticanres.17431.
9
Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment.工程化外泌体携带 miR-588 通过重塑免疫抑制微环境治疗三阴性乳腺癌。
Int J Nanomedicine. 2024 Jan 23;19:743-758. doi: 10.2147/IJN.S440619. eCollection 2024.
10
Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.新型组蛋白去乙酰化酶抑制剂YCW1与放疗联合通过下调三阴性乳腺癌细胞中BNIP3在体外和原位小鼠模型中诱导自噬性细胞死亡。
Mol Cancer. 2016 Jun 10;15(1):46. doi: 10.1186/s12943-016-0531-5.

本文引用的文献

1
In silico analysis and comprehensive review of circular-RNA regulatory roles in breast diseases; a step-toward non-coding RNA precision.基于计算分析的循环 RNA 在乳腺疾病中调控作用的综合综述:迈向非编码 RNA 精准治疗的一步
Pathol Res Pract. 2024 Nov;263:155651. doi: 10.1016/j.prp.2024.155651. Epub 2024 Oct 19.
2
Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine.与未来的治疗创新相比,当前一刀切疗法的进步:迈向个性化医疗的一步,以获得更好的化疗效果。
Curr Med Res Opin. 2024 Nov;40(11):1943-1961. doi: 10.1080/03007995.2024.2416985. Epub 2024 Oct 21.
3
Unraveling the ncRNA landscape that governs colorectal cancer: A roadmap to personalized therapeutics.
解析调控结直肠癌的 ncRNA 图谱:迈向个体化治疗的蓝图。
Life Sci. 2024 Oct 1;354:122946. doi: 10.1016/j.lfs.2024.122946. Epub 2024 Aug 8.
4
Hinokitiol Inhibits Breast Cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway.β-柏木脑通过 CD44/Nanog/SOX2/Oct4 通路抑制乳腺癌细胞体外干性进展和自我更新并诱导细胞凋亡和自噬。
Int J Mol Sci. 2024 Mar 31;25(7):3904. doi: 10.3390/ijms25073904.
5
MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research.MIBlood-EV:提高血液细胞外囊泡研究质量和可重复性的最低信息要求。
J Extracell Vesicles. 2023 Dec;12(12):e12385. doi: 10.1002/jev2.12385.
6
Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.鼻息肉抗体分泌细胞在阿司匹林加重的呼吸道疾病中表现出增殖特征。
J Allergy Clin Immunol. 2024 Feb;153(2):527-532. doi: 10.1016/j.jaci.2023.10.011. Epub 2023 Oct 28.
7
EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer.EMT 通过激活胞吐 Rabs 来协调肺癌的侵袭和免疫抑制。
Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2220276120. doi: 10.1073/pnas.2220276120. Epub 2023 Jul 5.
8
RIP1 Mediates Manzamine-A-Induced Secretory Autophagy in Breast Cancer.RIP1 介导线粒体自噬在乳腺癌中的作用。
Mar Drugs. 2023 Feb 25;21(3):151. doi: 10.3390/md21030151.
9
Autophagy and autophagy-related pathways in cancer.自噬和癌症中的自噬相关途径。
Nat Rev Mol Cell Biol. 2023 Aug;24(8):560-575. doi: 10.1038/s41580-023-00585-z. Epub 2023 Mar 2.
10
GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.GPR143控制依赖内体分选转运复合体(ESCRT)的外泌体生物发生,并促进癌症转移。
Dev Cell. 2023 Feb 27;58(4):320-334.e8. doi: 10.1016/j.devcel.2023.01.006. Epub 2023 Feb 16.